Evidence map›Paper›PMID 33219449›Full record

ReviewAnalytical and bioanalytical chemistry2021

Current methods for diagnosis of human coronaviruses: pros and cons.

Mercy R Benzigar, Ripon Bhattacharjee, Mahroo Baharfar, Guozhen Liu

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Analytical and bioanalytical chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Advances in rapid detection of SARS-CoV-2 by mass spectrometry.Trends in analytical chemistry : TRAC · 2022
    Review
  11. Article
  12. Comparative Analysis of SARS-CoV-2 Detection Kits.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2022
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mercy R BenzigarGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Ripon BhattacharjeeGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Mahroo BaharfarGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia.
Guozhen LiuGraduate School of Biomedical Engineering, University of New South Wales, Sydney, NSW, 2052, Australia. guozhen.liu@unsw.edu.au.

Funding

Australian Research Council FT160100039
6 · The paper itself

Abstract

The current global fight against coronavirus disease (COVID-19) to flatten the transmission curve is put forth by the World Health Organization (WHO) as there is no immediate diagnosis or cure for COVID-19 so far. In order to stop the spread, researchers worldwide are working around the clock aiming to develop reliable tools for early diagnosis of severe acute respiratory syndrome (SARS-CoV-2) understanding the infection path and mechanisms. Currently, nucleic acid-based molecular diagnosis (real-time reverse transcription polymerase chain reaction (RT-PCR) test) is considered the gold standard for early diagnosis of SARS-CoV-2. Antibody-based serology detection is ineffective for the purpose of early diagnosis, but a potential tool for serosurveys, providing people with immune certificates for clearance from COVID-19 infection. Meanwhile, there are various blooming methods developed these days. In this review, we summarise different types of coronavirus discovered which can be transmitted between human beings. Methods used for diagnosis of the discovered human coronavirus (SARS, MERS, COVID-19) including nucleic acid detection, gene sequencing, antibody detection, antigen detection, and clinical diagnosis are presented. Their merits, demerits and prospects are discussed which can help the researchers to develop new generation of advanced diagnostic tools for accurate and effective control of human coronavirus transmission in the communities and hospitals.

Indexed as

AnimalsBiosensing TechniquesCoronavirusCoronavirus InfectionsCOVID-19COVID-19 TestingEnzyme-Linked Immunosorbent AssayHumansImmunoassayMiddle East Respiratory Syndrome CoronavirusMolecular Diagnostic TechniquesReal-Time Polymerase Chain ReactionSARS-CoV-2Serologic TestsSevere Acute Respiratory SyndromeSevere acute respiratory syndrome-related coronavirusBiosensorsCOVID-19Human coronavirusesMolecular diagnosticsSerology detection

Identifiers

PMID33219449
PMCPMC7679240

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.